Opthea : Quarterly Activity Report - Form 6-K
Quarterly Activity Report Q3 FY24 Highlights • Completion of enrolment in first trial of sozinibercept's Phase 3 pivotal program...
Source: marketscreener.com
Fred Guerard News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Fred Guerard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Fred Guerard Today - Breaking & Trending Today
Opthea : to Present at the OIS Retina Innovation Summit at ARVO - Form 6-K
Opthea to Present at the OIS Retina Innovation Summit at ARVO Melbourne, Australia and Princeton, NJ, April 25, 2024 -- Opthea Limited , a clinical-stage biopharmaceutical...
Source: marketscreener.com
Opthea Appoints John Han, PharmD, as VP Medical Affairs
Brings extensive experience in retinal and ophthalmology diseases...
Source: globenewswire.com
Opthea Appoints Sujal Shah to the Board of Directors
Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee ChairMELBOURNE, Australia and PRINCETON, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced the appointment
Source: yahoo.com
Opthea Appoints Sujal Shah to the Board of Directors
Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee Chair...
Source: globenewswire.com